Compare Bilibili Inc (BILI) vs Core Scientific Inc (CORZ) Price & Performance

Bilibili (BILI) trades at $17.59, down 0.62% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.19, beating expectations, and maintains strong analyst support with 83.3% buy ratings. Revenue growth is steady, projected at $30.8B for 2026, with improving net income margins. Recent news highlights a new $300 million share repurchase program, signaling confidence in long-term value.

The outlook for BILI is cautiously optimistic, driven by earnings beats and shareholder-friendly actions, but risks include competitive pressures in the Chinese digital media space and technical bearishness. Upside potential hinges on sustained user growth and margin expansion, while volatility from market sentiment poses a near-term challenge.

Core Scientific (CORZ) trades at $22.71, down 3.32% today, with a bearish technical signal despite strong analyst support. The company is transitioning from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. However, the company continues to report significant losses with a net income margin of -341.68% and negative cash flow of $525.6M in 2025.

The outlook remains speculative with substantial execution risk despite analyst optimism. While the AI pivot offers growth potential, persistent losses and cash burn present significant challenges. The consensus price target of $34.17 suggests 50% upside potential, but investors must weigh the high-risk transformation against the company's current financial instability.